Cargando…
Safety and immunogenicity of inactivated COVID-19 vaccine in patients with metabolic syndrome: A cross-sectional observational study
BACKGROUND AND AIMS: The prevalence of metabolic syndrome (MS), wich mainly including hypertension, hyperglycemia, hyperlipidemia, remains high, and the safety and antibody response of inactivated coronavirus disease 2019 (COVID-19) vaccination in patients with metabolic syndrome (MS) is still incon...
Autores principales: | Guo, Qiao, Yang, Lei, Peng, Ran, Gao, Tao, Chu, Xinglin, Jiang, Depeng, Ke, Dazhi, Ren, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817001/ https://www.ncbi.nlm.nih.gov/pubmed/36620297 http://dx.doi.org/10.3389/fpubh.2022.1067342 |
Ejemplares similares
-
The safety and immunogenicity to inactivated COVID-19 vaccine in patients with hyperlipemia
por: Yang, Lei, et al.
Publicado: (2023) -
The safety and immunogenicity of inactivated COVID-19 vaccine in old pulmonary tuberculosis patients
por: Yang, Lei, et al.
Publicado: (2023) -
Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
por: Han, Shanshan, et al.
Publicado: (2023) -
Immunogenicity of Inactivated SARS-CoV-2 Vaccines in Patients With Rheumatoid Arthritis: A Case Series
por: Zhao, Ting, et al.
Publicado: (2022) -
Efficacy, immunogenicity and safety of HPV vaccination in Chinese population: A meta-analysis
por: Guo, Jianming, et al.
Publicado: (2023)